No Korean Banks in Anthropic's $90.4 Billion IPO: Why Seoul Is Sitting Out
Anthropic's $90.4 billion IPO has 22 underwriters and none is Korean. After Mirae Asset's failed SpaceX allocation, the FSS is urging restraint in marketing IPO-linked products.
Why it matters
- Anthropic's planned IPO could raise a record-high $90.4 billion.
- None of the 22 underwriters in Anthropic's SEC S-1 filing is a Korean brokerage.
- Mirae Asset Securities received no SpaceX IPO allocation in May, triggering an FSS on-site inspection and a full-compensation pledge.
- On Oct. 30 the FSS met asset managers and brokerages to review Anthropic IPO preparations, urging marketing restraint.
- Some SpaceX-exposed space-themed ETFs that bought post-IPO are down more than 50 percent.
Anthropic's planned initial public offering could raise a record-high $90.4 billion — and not a single Korean brokerage made the underwriter list. Korea's brokerages and asset managers are responding to the deal with visible caution, industry officials said Sunday, a sharp reversal from the enthusiasm that surrounded earlier U.S. mega-listings.
The S-1 registration statement Anthropic filed with the U.S. Securities and Exchange Commission names 22 underwriters. None of them is Korean. That absence has a direct consequence: Korean retail investors are unlikely to get access to shares through the IPO itself.
The number explains why this story matters. A $90.4 billion raise would be a record for an IPO, and Korean money has historically chased exposure to U.S. tech listings. Instead, Seoul's financial industry is holding back — because the last time it chased a blockbuster U.S. IPO, it ended in losses, regulatory inspections and client compensation.
What happened with SpaceX's IPO?
The caution traces back to Mirae Asset Securities and SpaceX's May IPO. Mirae Asset joined the U.S. underwriting syndicate, aiming to give Korean investors access to the offering. It ultimately received no allocation at all.
The fallout was immediate. The Financial Supervisory Service (FSS), Korea's financial regulator, conducted an on-site inspection of the brokerage. Mirae Asset Securities then pledged full compensation for affected clients.
Asset managers came under scrutiny too. Several had aggressively marketed ETFs on the promise of gaining direct exposure to SpaceX's IPO shares. When Mirae Asset failed to secure an allocation, those expectations collapsed — and regulators took notice.
Retail investors who bought into the post-IPO frenzy fared worse. Some space-themed ETFs with exposure to SpaceX have fallen by more than 50 percent, according to the report.
The lesson the industry drew is blunt: promising access to a U.S. IPO you don't control carries regulatory and reputational risk.
How can Koreans still invest in Anthropic?
ETFs remain the open door. Major Korean asset managers — Mirae Asset, KB, NH-Amundi and Samsung Asset Management — have launched a range of related ETFs since news of Anthropic's IPO plan emerged.
These funds carry provisions allowing their index committees to consider adding AI companies such as Anthropic once they go public in the United States. So direct-or-indirect exposure is technically possible after the listing.
But the marketing tells a different story. Asset managers are emphasizing broader investment themes — U.S. technology, large language models, agentic AI — rather than Anthropic itself. No fund is being sold as an Anthropic vehicle.
That framing is deliberate. After the SpaceX episode, tying a product's pitch to one specific U.S. listing invites exactly the kind of regulatory attention the industry is trying to avoid.
What is the regulator doing?
The FSS has extended its scrutiny from SpaceX to Anthropic's deal. On Oct. 30, the regulator met with asset managers and brokerages to review their investment plans and product preparations.
At that meeting, the FSS urged firms to exercise restraint in marketing IPO-related products. The message was clear: don't repeat the SpaceX playbook of hype-first promotion.
The meeting covered both sides of the trade — how firms plan to invest and how they plan to package and sell products to the public.
For Korean brokerages, the regulator's posture adds another reason to stay off the underwriter list rather than another barrier. Joining a syndicate with no guarantee of allocation already proved costly once.
Why do valuations make it worse?
Regulatory caution isn't the only brake. Concerns over stretched AI valuations are adding to the industry's hesitancy.
The evidence is already on Korean investors' statements. Those space-themed ETFs that bought SpaceX shares during the post-IPO frenzy and are now down more than 50 percent serve as a live warning about buying into hype at listing prices.
Asset managers don't want a repeat with AI-themed products. The muted approach — broad themes, careful marketing, index-driven inclusion rather than listing-day exposure — is designed to avoid repeating that loss profile.
The stakes cut both ways. Anthropic is one of the highest-profile AI companies heading to public markets, and a $90.4 billion raise would test whether investor appetite for AI matches the sector's private valuations. Korea's financial industry, burned once and watched closely by its regulator, has decided it would rather arrive late than overpay at the door.
Whether that restraint holds once Anthropic actually lists — and index committees begin weighing whether to add it — will be the test of how deeply the SpaceX hangover still bites.
Source: feed.koreatimes.co.kr
More from Sophie Lindqvist
Show full bio
Staff writer covering regulation, policy and their impact on artificial intelligence and machine learning at AI In Context.
625 articles
Related articles
- Anthropic Pulls $70-to-$80 IPO Price Range 80 Minutes After It Leaked
- Anthropic Targets Up to $1.405 Trillion Valuation in Nasdaq IPO Filing
- Anthropic’s $100 Billion IPO Roadshow Meets a Volatile Market
- Anthropic’s IPO Filing Shows $16B Revenue and $80.7M Loss
- Anthropic’s $1.5 trillion IPO tests the $1 trillion mark